Research & Literature

Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.

Piers SR, Everaerts K, van der Geest RJ, et al.

Heart rhythm 2015; (12(10)):2106-14.

Distribution of Ventricular Fibrosis Associated With Life-Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy.

Chimura M, Kiuchi K, Okajima K, et al.

Journal of cardiovascular electrophysiology 2015; (26(11)):1239-1246 doi:10.1111/jce.12767.

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.

Morales A, Hershberger RE

The Canadian journal of cardiology 2015; (31(11)):1309-12.

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Pinto YM, Elliott PM, Arbustini E, et al.

European heart journal 2016; (37(23)):1850-8 doi:10.1093/eurheartj/ehv727.

Cardiac sarcoidosis with severe involvement of the right ventricle: a case report.

Siqueira WC, da Cruz SG, Asimaki A, et al.

Autopsy & case reports 2015; (5(4)):53-63 doi:10.4322/acr.2015.030.

Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.

Karatolios K, Holzendorf V, Richter A, et al.

International journal of cardiology 2016; (220()):608-12.

Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.

Kayvanpour E, Sedaghat-Hamedani F, Amr A, et al.

Clinical research in cardiology : official journal of the German Cardiac Society 2017; (106(2)):127-139 doi:10.1007/s00392-016-1033-6.

Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers.

de Gonzalo-Calvo D, Quezada M, Campuzano O, et al.

International journal of cardiology 2017; (228()):870-880 doi:10.1016/j.ijcard.2016.11.045.

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.

Halliday BP, Gulati A, Ali A, et al.

Circulation 2017; (135(22)):2106-2115 doi:10.1161/CIRCULATIONAHA.116.026910.

Genotype-specific pathogenic effects in human dilated cardiomyopathy.

Bollen IAE, Schuldt M, Harakalova M, et al.

The Journal of physiology 2017; (595(14)):4677-4693 doi:10.1113/JP274145.

Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy.

Janin A, N'Guyen K, Habib G, et al.

Clinical genetics 2017; (92(6)):616-623 doi:10.1111/cge.13043.

Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography.

Mathew T, Williams L, Navaratnam G, et al.

Echo research and practice 2017; (4(2)):G1-G13.

Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases.

Hilty MP, Franzen DP, Wyss C, et al.

Annals of intensive care 2017; (7(1)):86 doi:10.1186/s13613-017-0307-0.

The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.

Becker MAJ, Cornel JH, van de Ven PM, et al.

JACC. Cardiovascular imaging 2018; (11(9)):1274-1284 doi:10.1016/j.jcmg.2018.03.006.

Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.

Begay RL, Graw SL, Sinagra G, et al.

JACC. Clinical electrophysiology 2018; (4(4)):504-514 doi:10.1016/j.jacep.2017.12.003.

Lamin missense mutations-the spectrum of phenotype variability is increasing.

Captur G, Bilińska Z, Arbustini E

European journal of heart failure 2018; (20(10)):1413-1416 doi:10.1002/ejhf.1290.

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.

Halliday BP, Wassall R, Lota AS, et al.

Lancet (London, England) 2019; (393(10166)):61-73 doi:10.1016/S0140-6736(18)32484-X.

Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.

Vita T, Gräni C, Abbasi SA, et al.

JACC. Cardiovascular imaging 2019; (12(8 Pt 2)):1659-1669 doi:10.1016/j.jcmg.2018.08.021.

Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: Implications for Genetic Testing and Clinical Management.

Peters S, Kumar S, Elliott P, et al.

Heart, lung & circulation 2019; (28(1)):31-38 doi:10.1016/j.hlc.2018.09.010.

A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.

Li Z, Chen P, Xu J, et al.

International journal of cardiology 2019; (279()):122-125 doi:10.1016/j.ijcard.2018.12.075.

Exercise Training and Heart Failure: A Review of the Literature.

Morris JH, Chen L

Cardiac failure review 2019; (5(1)):57-61 doi:10.15420/cfr.2018.31.1.

Ventricular Standstill in a Patient With a Left Ventricular Assist Device.

Fukunaga N, Nedadur R, Badiwala MV, et al.

The Annals of thoracic surgery 2019; (108(3)):e153-e155 doi:10.1016/j.athoracsur.2019.01.066.

Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice.

Rehmani T, Salih M, Tuana BS

Molecules (Basel, Switzerland) 2019; (24(6)) doi:10.3390/molecules24061189.

Small RNA-sequencing identified the potential roles of neuron differentiation and MAPK signaling pathway in dilated cardiomyopathy.

Huang G, Cao M, Huang Z, et al.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019; (114()):108826 doi:10.1016/j.biopha.2019.108826.

Myocardial Fibrosis as a Pathway of Prediction of Ventricular Arrhythmias and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy.

Centurión OA, Alderete JF, Torales JM, et al.

Critical pathways in cardiology 2019; (18(2)):89-97 doi:10.1097/HPC.0000000000000171.

Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants.

Haggerty CM, Damrauer SM, Levin MG, et al.

Circulation 2019; (140(1)):42-54 doi:10.1161/CIRCULATIONAHA.119.039573.

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators.

Corden B, Jarman J, Whiffin N, et al.

JAMA network open 2019; (2(6)):e196520 doi:10.1001/jamanetworkopen.2019.6520.

Association of galectin-3 with changes in left ventricular function in recent-onset dilated cardiomyopathy.

Rieth AJ, Jung C, Gall H, et al.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2019; (24(7)):652-658 doi:10.1080/1354750X.2019.1642959.

RNA sequencing reveals abnormal LDB3 splicing in sudden cardiac death.

Yamamoto T, Miura A, Itoh K, et al.

Forensic science international 2019; (302()):109906 doi:10.1016/j.forsciint.2019.109906.

Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa.

Bailly C, Henriques S, Tsabedze N, Krause A

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2019; (109(9)):673-678 doi:10.7196/SAMJ.2019.v109i9.13936.

Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype.

Skjølsvik ET, Hasselberg NE, Dejgaard LA, et al.

Journal of the American Heart Association 2020; (9(2)):e012937 doi:10.1161/JAHA.119.012937.

Emerging concepts in arrhythmogenic dilated cardiomyopathy.

Zegkos T, Panagiotidis T, Parcharidou D, Efthimiadis G

Heart failure reviews 2021; (26(5)):1219-1229 doi:10.1007/s10741-020-09933-z.

Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome.

Lombardo B, D'Argenio V, Monda E, et al.

Molecular genetics & genomic medicine 2020; (8(7)):e1260 doi:10.1002/mgg3.1260.

Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle.

Porcari A, De Luca A, Grigoratos C, et al.

Heart failure reviews 2022; (27(1)):49-69 doi:10.1007/s10741-020-09986-0.

Implementation of coronary computed tomography angiography as nationally recommended first-line test in patients with suspected chronic coronary syndrome: impact on the use of invasive coronary angiography and revascularization.

Nissen L, Winther S, Schmidt M, et al.

European heart journal. Cardiovascular Imaging 2020; (21(12)):1353-1362 doi:10.1093/ehjci/jeaa197.

Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives.

Hey TM, Rasmussen TB, Madsen T, et al.

Circulation. Heart failure 2020; (13(10)):e006701 doi:10.1161/CIRCHEARTFAILURE.119.006701.

Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.

Xu Y, Li W, Wan K, et al.

Circulation. Heart failure 2021; (14(1)):e007944 doi:10.1161/CIRCHEARTFAILURE.120.007944.

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.

Behera DR, V K AK, K K NN, et al.

Indian heart journal 2020; (72(5)):362-368 doi:10.1016/j.ihj.2020.06.011.

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging.

Stătescu C, Ureche C, Enachi Ș, et al.

Diagnostics (Basel, Switzerland) 2021; (11(4)) doi:10.3390/diagnostics11040625.

Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.

Li M, Xia S, Xu L, et al.

Journal of translational medicine 2021; (19(1)):189 doi:10.1186/s12967-021-02832-3.

Nonischemic cardiomyopathy with reduced ejection fraction secondary to hyperthyroidism.

Martin MM, Collins MR

JAAPA : official journal of the American Academy of Physician Assistants 2021; (34(6)):27-30 doi:10.1097/01.JAA.0000735812.69357.c5.

Next-Generation Sequencing Reveals Novel Genetic Variants for Dilated Cardiomyopathy in Pediatric Chinese Patients.

Wang Y, Han B, Fan Y, et al.

Pediatric cardiology 2022; (43(1)):110-120 doi:10.1007/s00246-021-02698-8.

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy.

Tayal U, Gregson J, Buchan R, et al.

Heart (British Cardiac Society) 2022; (108(8)):619-625 doi:10.1136/heartjnl-2021-319418.

Dilated cardiomyopathy: the role of genetics, highlighted in a family with Filamin C (FLNC) variant.

Dungu JN, Langley SG, Hardy-Wallace A, et al.

Heart (British Cardiac Society) 2022; (108(9)):676-682 doi:10.1136/heartjnl-2021-319682.

Filamin C in cardiomyopathy: from physiological roles to DNA variants.

Song S, Shi A, Lian H, et al.

Heart failure reviews 2022; (27(4)):1373-1385 doi:10.1007/s10741-021-10172-z.

Laminopathies: should Wenckebach be a cause for concern? A case report.

Sen G, Jackson T

European heart journal. Case reports 2021; (5(11)):ytab331 doi:10.1093/ehjcr/ytab331.

Phospholamban p.Arg14del Cardiomyopathy: A Japanese Case Series.

Tabata T, Kuramoto Y, Ohtani T, et al.

Internal medicine (Tokyo, Japan) 2022; (61(13)):1987-1993 doi:10.2169/internalmedicine.8594-21.

Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy.

Aiad N, Elnabawai YA, Li B, et al.

Heart, lung & circulation 2022; (31(6)):815-821 doi:10.1016/j.hlc.2021.12.014.

Molecular studies in familial dilated cardiomyopathy - A pilot study.

Mori V, Sawhney JPS, Verma IC, et al.

International journal of cardiology. Heart & vasculature 2022; (40()):101023 doi:10.1016/j.ijcha.2022.101023.

Successful heart transplantation in a patient with adolescent-onset dilated cardiomyopathy secondary to propionic acidaemia: a case report.

Seguchi O, Toda K, Hamada Y, et al.

European heart journal. Case reports 2022; (6(6)):ytac202 doi:10.1093/ehjcr/ytac202.

Combination therapy of liothyronine and levothyroxine for hypothyroidism-induced dilated cardiomyopathy.

Choi Y, Jung SY, Park JM, et al.

Annals of pediatric endocrinology & metabolism 2023; (28(2)):144-148 doi:10.6065/apem.2142218.109.

The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.

Cirino AL, Harris SL, Murad AM, et al.

Journal of genetic counseling 2022; (31(6)):1290-1305 doi:10.1002/jgc4.1604.

Natural History of MYH7-Related Dilated Cardiomyopathy.

de Frutos F, Ochoa JP, Navarro-Peñalver M, et al.

Journal of the American College of Cardiology 2022; (80(15)):1447-1461 doi:10.1016/j.jacc.2022.07.023.

Non-ischaemic dilated cardiomyopathy: recognising the genetic links.

Paul C, Peters S, Perrin M, et al.

Internal medicine journal 2023; (53(2)):178-185 doi:10.1111/imj.15921.

Family Screening in Dilated Cardiomyopathy: Prevalence, Incidence, and Potential for Limiting Follow-Up.

Vissing CR, Espersen K, Mills HL, et al.

JACC. Heart failure 2022; (10(11)):792-803 doi:10.1016/j.jchf.2022.07.009.

Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy.

Nishiyama T, Zhang Y, Cui M, et al.

Science translational medicine 2022; (14(672)):eade1633 doi:10.1126/scitranslmed.ade1633.

Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy.

Lau C, Gul U, Liu B, et al.

Medicina (Kaunas, Lithuania) 2023; (59(3)) doi:10.3390/medicina59030439.

Heart failure with reduced ejection fraction: What's new in the 2022 guideline?

Kittleson MM

Cleveland Clinic journal of medicine 2023; (90(4)):215-220 doi:10.3949/ccjm.90a.22101.

Genetic Screening Reveals Heterogeneous Clinical Phenotypes in Patients with Dilated Cardiomyopathy and Troponin T2 Variants.

Weis A, Krueck S, Dombrowsky G, et al.

Journal of personalized medicine 2023; (13(4)) doi:10.3390/jpm13040611.

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.

Jansen M, de Brouwer R, Hassanzada F, et al.

JACC. Heart failure 2024; (12(1)):134-147 doi:10.1016/j.jchf.2023.07.007.

The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.

Kan A, Fang Q, Li S, et al.

ESC heart failure 2023; (10(6)):3340-3351 doi:10.1002/ehf2.14529.

Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.

Heymans S, Lakdawala NK, Tschöpe C, Klingel K

Lancet (London, England) 2023; (402(10406)):998-1011 doi:10.1016/S0140-6736(23)01241-2.

Genetics of Dilated Cardiomyopathy.

Eldemire R, Mestroni L, Taylor MRG

Annual review of medicine 2024; (75()):417-426 doi:10.1146/annurev-med-052422-020535.

Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.

Bednar EM, Rauh-Hain JA, Garcia JJ, et al.

Cancer prevention research (Philadelphia, Pa.) 2024; (17(1)):19-28 doi:10.1158/1940-6207.CAPR-23-0303.

Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging.

Santoro F, Vitale E, Ragnatela I, et al.

Heart failure reviews 2024; (29(2)):445-462 doi:10.1007/s10741-023-10373-8.

Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review.

Politano L

International journal of molecular sciences 2024; (25(10)) doi:10.3390/ijms25105289.

Troponin T Assessment Allows for Identification of Mutation Carriers among Young Relatives of Patients with LMNA-Related Dilated Cardiomyopathy.

Chmielewski P, Kowalik I, Truszkowska G, et al.

Journal of clinical medicine 2024; (13(11)) doi:10.3390/jcm13113164.

A Unique Case of Goodpasture's Syndrome-Induced Cardiorenal Syndrome.

Chinniah C, Pyronneau A, Stepman G, Ali R

Cureus 2024; (16(7)):e64269 doi:10.7759/cureus.64269.

The role of genetic testing in management and prognosis of individuals with inherited cardiomyopathies.

Hespe S, Gray B, Puranik R, et al.

Trends in cardiovascular medicine 2025; (35(1)):34-44 doi:10.1016/j.tcm.2024.06.002.

Impact of exercise training on clinical outcomes and quality of life in chronic congestive heart failure: A systematic review and meta-analysis.

Al Hennawi H, Bedi A, Khan MK, et al.

Current problems in cardiology 2024; (49(10)):102756 doi:10.1016/j.cpcardiol.2024.102756.

Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective.

Widmer RJ, Rosol ZP, Banerjee S, et al.

Journal of the Society for Cardiovascular Angiography & Interventions 2024; (3(3Part B)):101301 doi:10.1016/j.jscai.2024.101301.

Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review.

Arnautu DA, Cozma D, Lala IR, et al.

Biomedicines 2024; (12(8)) doi:10.3390/biomedicines12081643.

Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.

Gigli M, Stolfo D, Merlo M, et al.

Nature reviews. Cardiology 2025; (22(3)):183-198 doi:10.1038/s41569-024-01074-2.

Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice.

Myers MC, Breznen B, Zhong Y, et al.

Cardiology research 2024; (15(5)):319-329 doi:10.14740/cr1679.

Association between cardiovascular risk factors and dilated and hypertrophic cardiomyopathy: Mendelian randomization analysis.

Zou C, Zou H, Jiang Y, et al.

Nutrition, metabolism, and cardiovascular diseases : NMCD 2025; (35(1)):103752 doi:10.1016/j.numecd.2024.09.022.

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy.

Feng XY, Zheng YC, Yang YX, et al.

Reviews in cardiovascular medicine 2025; (26(1)):25654 doi:10.31083/RCM25654.

RBM20 p.Arg636Cys: A Pathogenic Variant Identified in a Family with Several Cases of Unexpected Sudden Deaths.

Lorca R, Alén A, Salgado M, et al.

Journal of clinical medicine 2025; (14(3)) doi:10.3390/jcm14030743.

The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series.

Del Mestre E, Capovilla TM, Paldino A, et al.

European heart journal. Case reports 2025; (9(4)):ytaf162 doi:10.1093/ehjcr/ytaf162.

Analysis of the current situation and influencing factors of internal perceptions in patients with chronic heart failure at the county level.

Yu M, Ge J, Jiang L, et al.

Frontiers in psychology 2025; (16()):1618068 doi:10.3389/fpsyg.2025.1618068.

What kind of information is requested by patients and families with genetic disorders? : The analysis of an online patient community in South Korea.

Lee SA, Park S, So MK, et al.

Journal of community genetics 2025; (16(6)):787-797 doi:10.1007/s12687-025-00827-x.

Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis.

Hu R, Yu L, Li J, et al.

Frontiers in cardiovascular medicine 2025; (12()):1575493 doi:10.3389/fcvm.2025.1575493.

Multiple intra-cavitary thrombi in a late-onset dilated cardiomyopathy with severely reduced ejection fraction: A case report and review of the literature.

Di Iorgi M, Valotta A, Rigamonti E, Scopigni F

JRSM cardiovascular disease 2025; (14()):20480040251395237 doi:10.1177/20480040251395237.

Truncating Titin and Lamin A/C Variants in Anthracycline-Induced Cardiomyopathy.

Advani PP, McPherson AD, Reddy JS, et al.

JACC. Advances 2026; (5(2)):102431 doi:10.1016/j.jacadv.2025.102431.

An integrative approach to identify novel miRNA-mRNA interaction networks in LMNA-cardiomyopathy.

Córdoba-Caballero J, Bonet F, Campuzano O, et al.

Scientific reports 2026; (16(1)):6110.

Right ventricular failure after LVAD support: A challenging case of bridge to heart transplantation in end-stage dilated cardiomyopathy.

Suciu H, Anitei ED, Calburean P, Harpa MM

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) 2026; (12(1)):102-109 doi:10.2478/jccm-2025-0038.